EMA Head On Drug Prices, Transparency, And What Patients Really Need
This article was originally published in Scrip
To get a clearer vision of the future, sometimes you need to stand back and take stock. And this, it seems, is what Guido Rasi, newly re-appointed executive director of the European Medicines Agency, has been doing during the year since he had to relinquish his post following a ruling by the EU's civil service tribunal.
Register for our free email digests: